p e r s p e c t i v e
Innate lymphoid cells (ILCs) are a family of innate immune cells that have diverse functions during homeostasis and disease. Subsets of ILCs have phenotypes that mirror those of polarized helper T cell subsets in their expression of core transcription factors and effector cytokines. Given the similarities between these two classes of lymphocytes, it is important to understand which functions of ILCs are specialized and which are redundant with those of T cells. Here we discuss genetic mouse models that have been used to delineate the contributions of ILCs versus those of T cells and review the current understanding of the specialized in vivo functions of ILCs.
In 1986, Mosmann and Coffman identified the T H 1 and T H 2 subsets of helper T cells by demonstrating that CD4 + T cell clones can be divided into two groups with distinct patterns of cytokine expression 1 . Those findings, together with the discovery of T H 17 cells almost two decades later, formed the helper T cell paradigm, a concept that functionally defined subsets of polarized CD4 + T cells by the specific cytokines they produce. Remarkably, a similar paradigm has emerged from the innate immune compartment with the discovery of a new group of lymphocytes called 'innate lymphoid cells' (ILCs). ILCs are a functionally diverse but developmentally related family of innate lymphocytes with phenotypes that resemble those of polarized T cell subsets. Specific cell types in this lymphocyte class have been recognized for decades; the first identified ILC, the conventional natural killer (cNK) cell, was discovered over 40 years ago 2 , while the lymphoid-tissue-inducer (LTi) cell was described in neonatal mouse lymph nodes in 1992 (ref. 3) . In subsequent years, additional cell types in this family have been identified [4] [5] [6] [7] [8] [9] [10] , which has generated increased interest in ILCs and their functions during homeostasis and inflammation.
With the recognition that innate lymphoid populations have striking similarities to polarized CD4 + T cell subsets, the ILC family was divided into three groups that parallel the T H 1, T H 2 and T H 17 subsets. Group 1 ILCs (ILC1s) are analogous to T H 1 cells, as they express the transcription factor T-bet and produce interferon-γ (IFN-γ). ILC1s include Eomes − IL-7R + ILC1s as well as Eomes + IL-7R − cNK cells, although cNK cells arise from a divergent developmental pathway and are perhaps more analogous to CD8 + cytotoxic T cells because they produce large amounts of granzymes and perforin. Eomes − ILC1s and Eomes + ILC1s represent two extremes of a broad spectrum of ILC1 phenotypes that were previously attributed to NK cell populations. These cells, which exhibit varying cytolytic activities and contrasting requirements for Eomes and other transcription factors such as T-bet and Nfil3, include intestinal intraepithelial ILC1s, salivary-gland ILC1s and uterine ILC1s [11] [12] [13] [14] . Group 2 ILCs (ILC2s) are analogous to T H 2 cells in that they have high expression of the transcription factor GATA-3 and produce interleukin 5 (IL-5), IL-9 and IL-13 during both helminth infection and allergic inflammation [4] [5] [6] . These cells are subcategorized on the basis of their responsiveness to the epithelial-cell-derived cytokines IL-33 and IL-25 (ref. 15 ). Finally, group 3 ILC3s (ILC3s) express the transcription factor RORγt 16 . These cells produce IL-22 and/or IL-17A during extracellular fungal or bacterial infection and are analogous to T H 17 cells. ILC3s include LTi cells, which are required for the development of secondary lymphoid tissues in the fetus 17 , as well as CCR6 + LTi-like cells, NKp46 + ILC3s and CCR6 − NKp46 − ILC3s in adult mice. In humans, ILC3s isolated from tonsils express the activating receptor NKp44 (ref. 8) .
Although ILCs and helper T cells have similar effector programs, these cells are regulated in distinct ways. The priming of naive CD4 + T cells requires the recognition of peptide-loaded major histocompatibility complex (MHC) molecules, and costimulatory molecules; both are provided by direct contact with an antigen-presenting cell. In contrast, ILCs do not require specific antigen or costimulation and are instead activated by an expanding list of soluble mediators that include proinflammatory cytokines, alarmins, lipids and hormones released by stromal, epithelial and myeloid populations. ILCs and CD4 + T cells also require different amounts of time to mount effector responses. T cell priming takes place over several days in lymphoid organs as these cells undergo activation and clonal expansion, acquire effector functions and produce the surface molecules required for migration to nonlymphoid tissues. In contrast, most ILCs take up permanent residence in nonlymphoid tissues at steady state 18 and are able to produce substantial amounts of cytokines upon stimulation without further differentiation. Thus, ILCs are physically and functionally poised to be immediate sources of effector cytokines in peripheral tissues, which places these cells among the ranks of other rapidly responding tissue-resident lymphocytes such as invariant NKT cells, γδ T cells and tissue-resident memory T cells (Fig. 1) . The limited activation requirements of ILCs allow them to serve as first responders during the early stages of a primary immune response, as well as to produce cytokines in response to subtle perturbations during homeostasis.
innate lymphoid cell function in the context of adaptive immunity Given the similar effector programs of ILCs and T cells, it is important to understand the unique contributions provided by ILCs in vivo. To distinguish the contributions of ILCs from those of T cells, the functions of ILCs are frequently investigated in T cell-deficient mice. For example, a common strategy is to compare the phenotypes of mice deficient in the Rag recombinase, which lack adaptive lymphocytes but have intact ILCs, with mice deficient in both Rag and the common γ-chain (γ c ), which lack both adaptive lymphocytes and ILCs. As a result, there remains a major gap in knowledge of the activities of ILCs under physiological settings. Studying ILCs in the context of an intact T cell compartment will be needed to identify functions of ILCs that are distinct from those of T cells and to determine how ILCs communicate with T cells during an immune response. Additionally, the shared and distinct regulatory elements that govern lineage determination and function in ILCs and T cells need to be explored. Expansion of these areas of research will be of particular importance if investigators propose to selectively modulate ILC function in patients to improve disease outcomes.
Mouse models for assessing ILC function
Early studies characterizing ILCs with Rag-deficient mice and Ragand γ c -deficient mice demonstrated that these cells are lymphocytes that require γ c cytokines to develop but are not of the T cell lineage. Since then, Rag-deficient mice have been essential for showing that cytokines derived from ILCs can promote microbial killing, granulocyte migration, epithelial barrier integrity, smooth-muscle contraction and mucus production in the context of T cell immunodeficiency. However, there are potential caveats associated with ILCs in Ragdeficient mice. ILC2s and ILC3s in Rag-deficient mice are elevated in number in tissues and can produce increased amounts of cytokine both at rest and after stimulation in vitro [19] [20] [21] [22] . These changes probably result from an excess of γ c cytokines that arises in the absence of T cells. IL-7, which promotes proliferation, survival and changes in fate 'decisions' of ILCs, is normally limited by T cell consumption in wild-type mice, but its concentration is increased in the serum of Rag-deficient mice 23 . These observations should be considered in assessment of the functional contributions of ILCs with this system. Moreover, although ILCs do not express rearranged antigenspecific receptors, a variable proportion of cNK cells, ILC2s and ILC3s express Rag-encoding genes during development and are altered by Rag deficiency in a cell-intrinsic manner 24, 25 . Rag-deficient ILCs have increased phosphorylation of histone H2AX, a marker of double stranded-DNA-break events, and Rag2 −/− cNK cells exhibit a reduced response to radiation-induced DNA damage relative to that of Rag2 +/+ cNK cells. Rag-deficient cNK cells also have reduced cellular fitness, with Rag2 −/− cNK cells displaying increased apoptosis at steady state and diminished survival after infection with murine cytomegalovirus. The cell-intrinsic effects of Rag deficiency on the cellular fitness of ILC2s and ILC3s are unknown.
A second commonly employed strategy for the study of ILC function relies on the depletion of ILCs with antibodies to the alloantigen Thy-1. Most ILCs and all T cells have high surface expression of Thy-1, and ILCs are thus largely eliminated via the administration of a depleting antibody to Thy-1 to Rag-deficient mice 26 . In some studies, chimeric mice with T cells that express a Thy-1 variant not recognized by depleting antibodies have been used for depletion of the ILC compartment without an effect on T cells 27 . Studies using the Thy-1-depletion system have reported variable efficiencies of cell depletion in blood and tissue, potentially due to the method of antibody administration 28, 29 . An important consideration with such studies is that Thy-1 expression is not restricted to lymphocytes, but Thy-1 is also expressed by several other cell types, including fibroblasts, endothelial cells, neurons, basophils and dendritic cells (DCs). The effects of treatment with antibody to Thy-1 on these cell types have not been fully explored.
Notably, use of the models described above has provided critical information about ILC biology and has moved the field forward to a point at which researchers can use more-advanced tools to start testing how ILCs function in the presence of adaptive immunity. So far, the overlapping genetic requirements of ILCs and T cells have made it difficult to manipulate innate lymphoid populations in mice without simultaneously altering T cell populations. As yet, no single transcription factor has been shown to be uniquely required by ILCs but not by In general, two strategies for genetic targeting of ILCs have been used to divide the innate and adaptive lymphoid compartments: using Cre-loxP systems to target two genes expressed by ILCs that in combination are minimally expressed or required by T cells; and driving expression of a loxP-flanked allele encoding the diphtheria-toxin receptor in both T cells and ILCs, then 'rescuing' T cells from expression of this receptor through T cell-specific expression of Cre recombinase. Some examples of effective Cre-recombinase lines that have been used to study ILC subsets, but that are not necessarily specific to ILCs, include Ncr1-Cre mice [30] [31] [32] , in which transgenic Cre expression is driven in all subsets of group 1 ILCs as well as NKp46 + ILC3s; Il5-Cre mice 33 , in which sequence encoding Cre knocked into Il5 results in targeting of not only ILC2s but also an IL-5-expressing subset of T H 2 cells; and Rorc-Cre mice 16 , in which transgenic Cre expression is driven in ILC3s, as well as in T cells during thymopoiesis. These mice have been crossed to mice with loxP-flanked alleles encoding various cytokines and transcription factors expressed by ILCs. A list of selected mouse models used for the study of ILCs is provided ( Table 1) .
The discovery of additional ILC-specific genes should allow more targeted manipulation of ILCs at different stages during development and maturation. Such genes are starting to be identified through the Immunological Genome Project, which has provided gene-expression analyses of intestinal ILC subsets 34 . Additional work directly comparing gene expression and regulation in analogous effector T cell and ILC subsets (for example, T H 2 cells versus ILC2s) will be important for the generation of tools to distinguish contributions by these populations 35 . Gene expression in ILC subsets should also be compared with that in tissue-resident memory T cells. These subsets of memory T cells, following expansion and differentiation, migrate into nonlymphoid tissues, where they reside without recirculating in the blood 36 . ILCs probably share more core transcriptional signatures with tissue-resident memory T cells than with effector T cell subsets, on the basis of their expression of genes encoding products associated with tissue residency and activation.
Studies of mouse models now available have revealed several unique functions of mouse ILCs during fetal and neonatal development, under steady-state conditions in adults and after irradiation. At this point, less is known about the non-redundant functions of ILCs during an immune response, although ILCs have been shown to regulate epithelial cells, T cells and myeloid populations during infection. Here we will discuss selected examples of unique activities of ILCs, while additional functions of ILCs are discussed in the companion Reviews in this issue.
ILCs in gestation and neonatal life
The organogenesis of secondary lymphoid tissues occurs in the fetus and is dependent on a specialized subset of ILC3s: LTi cells 17 . During fetal development, LTi cells and their precursors develop in the fetal liver and migrate to peripheral tissues, where they undergo further maturation and induce the development of lymph nodes and Peyer's patches via lymphotoxin-α 1 β 2 (ref. 37) . Interactions between LTi cells expressing lymphotoxin-α 1 β 2 and stromal cells expressing the lymphotoxin-β receptor initiate development by inducing stromal production of adhesion molecules and chemokines, including VCAM-1, the chemokine receptor CXCR5 ligand CXCL13, and the chemokine receptor CCR7 ligands CCL19 and CCL21. These factors initiate a positive feedback loop by locally recruiting additional LTi cells and ILC precursor populations to the developing lymphoid organ. The absence of LTi cells (as in Rorc −/− mice), lymphotoxin signaling (as in mice deficient in lymphotoxin-α, lymphotoxin-β or the lymphotoxin-β receptor), or CXCR5 and/or CCR7 leads to severe deficiency in or complete abrogation of the development of secondary lymphoid tissues.
The postnatal development of tertiary lymphoid organs in the gut is similarly driven by ILC3s. NKp46 − LTi-like ILC3s induce the development of cryptopatches and isolated lymphoid follicles though activation of signaling via the lymphotoxin-β receptor 38, 39 . However, unlike the organogenesis of secondary lymphoid tissues, the development of tertiary lymphoid tissues in the gut requires additional signals from the environment. Peptidoglycan from intestinal microbes drives the development of isolated lymphoid follicles in a manner dependent on the cytosolic pattern-recognition receptor Nod1 (ref. 40) . In addition, aryl hydrocarbon receptor (AHR), a sensor of diet-or microbederived or endogenously derived planar aromatic hydrocarbons, is required for normal population expansion of adult ILC3s in the small intestine [41] [42] [43] . Thus, tertiary lymphoid structures are absent in AHRdeficient mice, while the development of secondary lymphoid tissues proceeds normally in the absence of AHR.
ILC1s have been linked to the promotion of vascular changes in the uterus during pregnancy. In humans, uterine spiral arteries undergo remodeling during pregnancy to increase the flow of blood and nutrients to the fetus and placenta. In mice, the equivalent vascular structures are the major decidual arteries, which undergo remodeling during pregnancy in an IFN-γ-dependent manner 44 . Data strongly suggest that ILC1s are required for this process. The remodeling of mouse uterine vasculature requires lymphocytes and IL-15, whereas T cells are not required for this 13, [44] [45] [46] . Notably, mice with Nfil3-deficient lymphocytes exhibit defects in uterine vascular remodeling 13, 47 . Nfil3-deficient mice lack uterine Eomes + CD49b + CD49a − cNK cells and have reduced numbers of a second uterine ILC1 subset that expresses the integrin CD49a (α 1 ) 13 , which suggests that these populations are important for normal vascular remodeling. Additional studies will be needed to determine the specific contributions of ILC1 subsets and the mechanisms behind uterine vascular remodeling.
Constitutive production of cytokines ILC2s actively secrete type 2 cytokines in the absence of infection. In naive mice, ILC2s produce the eosinophil growth factor IL-5 in the heart, kidney, lungs, muscle, skin, gut and uterus 33 . The secretion of IL-5 follows circadian rhythms regulated by food intake, with serum IL-5 concentrations and blood eosinophil frequencies elevated at the beginning of the light cycle and reduced at the beginning of the dark cycle, as well as after fasting. Although the effects of circadian IL-5 secretion and blood eosinophil levels on host physiology are unclear, the induction of this pathway following food intake suggests that IL-5 and eosinophils might have roles in regulating dietary metabolism. Indeed, increased adiposity has been observed in eosinophil-deficient mice 48 .
ILC2s have been shown to regulate the development of a specialized gut epithelial lineage: the tuft (or brush) cell [49] [50] [51] . Tuft cells have been suggested to be sentinel cells that detect parasitic worms. This epithelial population is a unique producer of IL-25, a cytokine of the IL-17 family that activates ILC2s. At steady state, intestinal ILC2s produce IL-13, which acts on the epithelial-stem-cell compartment p e r s p e c t i v e at the base of the crypt-villus axis to promote a basal level of tuft-cell development. In turn, tuft cells produce IL-25 at a level that maintains steady-state activation of ILC2s. During infection with worms, this regulatory circuit between tuft cells and ILC2s is enhanced in a manner dependent on the tuft-cell chemosensory signaling molecule Trpm5 (ref. 50) , which leads to tuft-cell and goblet-cell hyperplasia and thereby promotes worm expulsion [49] [50] [51] . Thus, ILC2s have unique functions in the pathways that detect the initial presence of parasitic worms in the gut.
ILC3s also actively produce effector cytokines at steady state. In unchallenged mice, ILC3s are the main source of IL-22, a cytokine that induces the proliferation and survival of intestinal epithelial cells. ILC3-derived IL-22 also induces production of the anti-microbial peptide RegIIIγ and α(1,2)-fucosylation of intestinal epithelial cells, which contribute to the maintenance of homeostatic interactions with gut microbiota 10, 52 . Intestinal NKp46 − ILC3s are located at the bases of intestinal crypts in cryptopatches, while NKp46 + ILC3s are widely distributed throughout the lamina propria. Thus, it is possible that these subsets might provide IL-22 to epithelial cells at different locations along the crypt-villus axis. It is not clear whether basal IL-22 production by ILC3s is induced by microbiota, since there are conflicting reports of whether intestinal flora induces or represses IL-22 production by ILC3s 7, 10, 19, 41 . Interestingly, gut epithelial IL-25 negatively regulates ILC3s, and IL-25 expression by the epithelium is reported to increase with age 19 . Future studies should shed light on how aging correlates with changes in ILC populations in the gut.
Finally, it has been proposed that NKp46 + and NKp46 − ILC3s in the gut constitutively produce the cytokine GM-CSF in response to IL-1β secreted by macrophages 53 . In the absence of GM-CSF, DC and macrophage populations are diminished in the colon. Additionally, DCs from GM-CSF-deficient mice have blunted production of the cytokine TGF-β, and macrophages from these same mice produce less IL-10 than do macrophages from wild-type mice. Thus, ILC3s may contribute to the maintenance of normal cellularity and myeloid functionality in the gut lamina propria under steady-state conditions through the production of GM-CSF.
Radioresistance
ILC3s have been observed to persist in mice exposed to lethal doses of γ-radiation. The radioresistance of these cells is presumably due to their slow cell-division rate 54 , which reduces the fraction of the population in radiosensitive phases of the cell cycle and might allow more time for DNA repair to take place. In contrast, T cells are extremely radiosensitive and are considerably reduced in number 3 d after irradiation.
Radioresistant ILC3s have been shown to protect mice from tissue damage induced by irradiation as well as allogeneic responses during graft-versus-host disease. In mice and humans, irradiation induces proliferating epithelial cells in intestinal crypts to undergo apoptosis 55 . This disrupts the crypt-villus organization and can create breaches in the intestinal epithelial barrier. Regeneration of the gut epithelium requires Lgr5 + intestinal stem cells, which reside at the bases of crypts and give rise to all lineages of gut epithelial cells 55, 56 . During graft-versus-host disease, IL-22 derived from radioresistant ILC3s protects this intestinal stem-cell pool. Graft-versus-host disease can be experimentally induced by transplantation of bone marrow and T cells from MHC-mismatched mice or from mice with mismatched minor histocompatibility antigens into irradiated mice. Mice that lack IL-22 have increased gut pathology, more-severe loss of intestinal stem cells and reduced survival in this model 57 .
Similarly, thymic regeneration after irradiation is enhanced by IL-22 secreted by radioresistant ILC3s. In the thymus, irradiation induces loss of thymocytes as well as loss of cortical and medullary thymic epithelial cells, which are required for positive and negative T cell selection. IL-22 expression is increased after irradiation and enhances 60, 62 , while another group has found that these mice develop spontaneous intestinal inflammation and rectal prolapse 61 . These differences might be due to the variations in microbial communities across mouse facilities. Although the mechanisms behind the enhanced T H 17 responses of H2-Ab1 fl/fl Rorc-Cre mice are not well understood, it has been proposed that ILC3s directly induce the death of microbe-specific CD4 + T cells via mechanisms similar to those that promote the negative selection of T cells in the thymus 63 . ILC3s migrate from the intestine to interfollicular regions of the draining mesenteric lymph nodes in a CCR7-dependent manner, and the effect of this trafficking on T cells is unclear 64 . Outside of the gut, loss of MHC class II expression by ILC3s is reported to lead to reduced T cell responses in the spleen in a model of adoptive transfer of OT-II cells (which have transgenic expression of an MHC-class-II-restricted T cell antigen receptor (TCR) 43 ; this suggests that the functions of MHC class II in ILC3s might be different across tissues. In ILC2s, expression of MHC class II is partly dependent on trogocytosis 65 . Similar to ILC3s, ILC2s do not induce T cell proliferation in vitro, although ILC2s might enhance T H 2 polarization in T cells stimulated with plate-bound antibody to the invariant signaling protein CD3 and antibody to the costimulatory receptor CD28 (refs. 65,66) . Instead, MHC-class-II-expressing ILC2s have been proposed to induce T cells to produce IL-2, which feeds back on ILC2s to promote activation 65 . ILCs also regulate T cells indirectly by modulating macrophage and DC function. During a primary response, IL-13 produced by ILC2s promotes the migration of DCs from the lungs to the draining lymph nodes, where these DCs prime naive T cells 67 . During a secondary response, IL-13 secreted by ILC2s induces IRF4 + CD11b + CD103 − DCs in the lungs and skin to produce CCL17, a ligand to the T H 2 cell-associated chemokine receptor CCR4 (ref. 68 ). In the absence of IL-13 or ILC2s during a recall response, CCL17 is not expressed in the lungs and the accumulation of memory T H 2 cells in the lungs is reduced. Likewise, ILC3-derived GM-CSF production in the gut induces macrophages and DCs to produce TGF-β and IL-10, which promote the population expansion of regulatory T cells 53 .
Overlapping roles of mouse T cells and ILCs during infection
The pathogen Citrobacter rodentium, a model for enteropathic Escherichia coli, has been used extensively to demonstrate that IL-22 has protective roles during intestinal inflammation. Both T cells and ILC3s produce IL-22 in this model. In studies of Rag2 −/− mice, ILC3s have been shown to be important for controlling infection. Infected Rag2 −/− mice have a survival advantage over Rag2 −/− mice that also lack the gene encoding γ c (ref. 7) , and depletion of IL-22 in Rag2 −/− mice decreases their survival 69 . Additionally, mice that lack IL-23, a cytokine that induces ILC3s to secrete IL-22, rapidly succumb to infection after inoculation with standard experimental doses of bacteria 69 . However, studies of mice with intact T cells have indicated that ILC3s can have redundant roles in this model. Mice infected with low doses of C. rodentium exhibit survival that is independent of IL-23 and, thus, is independent of ILC3s 70 . Instead, IL-22-expressing CD4 + T cells are crucial for survival after infection with low-dose inocula. Notably, mice lacking functional NKp46 + ILC3s exhibit no difference in survival or weight loss compared with that of wild-type mice after infection with standard inocula 71, 72 , which indicates that NKp46 + ILC3s are not required for host protection against C. rodentium. However, mice deficient in NKp46 + ILC3s develop ulceration and bleeding in the cecum during infection, which indicates that these cells have other specialized functions in this model that still need to be characterized 72 .
Comparison of ILCs and T cells in humans
Genome-wide comparisons of the transcriptomes and epigenomes of human ILC and helper T cell subsets have been performed 73 
Concluding remarks
The overlapping and unique functions of ILCs and T cells are still being defined in mice and humans. The development of more-specific genetic tools with which to study ILCs in mice will be crucial for the identification of specialized activities of these cells in disease states. Expansion of this area and of research characterizing regulatory pathways in these cells will be essential for the identification of therapeutic interventions for human diseases that act either selectively on ILCs or collectively on lymphocytes.
